Stock Market Update
12-Oct-26 12:05 ET
Health care sector modestly higher
Dow +245.12
at 51900.28,
Nasdaq -54.08
at 27333.03,
S&P +4.51
at 7816.12
[BRIEFING.COM] The major averages remain mixed at midday.
Biogen (BIIB 234.33, +8.62, +3.82%) is one of the best-performing S&P 500 sectors today after being upgraded to Overweight from Neutral at JPMorgan, with a target price of $300.
The health care sector (+0.3%) trades modestly higher, but is held back by some weakness in biotechnology stocks, with the iShares Biotechnology ETF down 0.7%.
Bristol-Myers (BMY 57.28, -1.84, -3.11%) has reversed a solid opening gain that followed positive Phase 3 readouts for RYZ101 and admilparant strengthened two differentiated growth opportunities as the company prepares for further legacy-product erosion.
